Press Releases
Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on Essential Healthcare News.
KALA BIO to Present at Jefferies Global Healthcare Conference
GlobeNewswire, Inc.
·
May 29, 2025
ARLINGTON, Mass., May 29, 2025 (GLOBE NEWSWIRE) -- KALA BIO, Inc. (NASDAQ:KALA), a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization of innovative therapies for rare and severe diseases of the...
Septerna to Present at Jefferies Global Healthcare Conference
GlobeNewswire, Inc.
·
May 29, 2025
SOUTH SAN FRANCISCO, Calif., May 29, 2025 (GLOBE NEWSWIRE) -- Septerna, Inc. (Nasdaq: SEPN), a biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) drug discovery, today announced that Jeffrey Finer, M.D., Ph.D., Chief...
Black Diamond Therapeutics to Participate in Jefferies Global Healthcare Conference
GlobeNewswire, Inc.
·
May 29, 2025
CAMBRIDGE, Mass., May 29, 2025 (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer, today...
Cabaletta Bio to Participate in the Jefferies Global Healthcare Conference
GlobeNewswire, Inc.
·
May 29, 2025
PHILADELPHIA, May 29, 2025 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on developing and launching the first curative targeted cell therapies designed specifically for patients with...
Immuneering to Present at the Jefferies Global Healthcare Conference
GlobeNewswire, Inc.
·
May 29, 2025
CAMBRIDGE, Mass., May 29, 2025 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a clinical-stage oncology company seeking to develop and commercialize more effective and better tolerated therapies for cancer patients, today announced...
Stoke Therapeutics to Present at the Jefferies Global Healthcare Conference
Business Wire
·
May 29, 2025
Stoke Therapeutics, Inc. (Nasdaq: STOK) is a biotechnology company dedicated to restoring protein expression by harnessing the body’s potential with RNA medicine and has a lead investigational medicine, zorevunersen, in development as a...
Maze Therapeutics to Participate in the Jefferies 2025 Global Healthcare Conference
GlobeNewswire, Inc.
·
May 29, 2025
SOUTH SAN FRANCISCO, Calif., May 29, 2025 (GLOBE NEWSWIRE) -- Maze Therapeutics, Inc. (Nasdaq: MAZE), a clinical-stage biopharmaceutical company developing small molecule precision medicines for patients with renal, metabolic and cardiovascular...
Crescent Biopharma to Present at the Jefferies Global Healthcare Conference
GlobeNewswire, Inc.
·
May 29, 2025
WALTHAM, Mass., May 29, 2025 (GLOBE NEWSWIRE) -- Crescent Biopharma, Inc. (“Crescent”), a private biotechnology company developing novel precision-engineered molecules targeting validated biology to advance care for patients with solid tumors,...
Aldeyra Therapeutics to Participate in the 2025 Jefferies Global Healthcare Conference
Business Wire
·
May 29, 2025
Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-mediated and metabolic diseases, today announced that Todd C. Brady, M.D., Ph.D.,...
Zenas BioPharma to Present at the Jefferies Global Healthcare Conference
GlobeNewswire, Inc.
·
May 29, 2025
WALTHAM, Mass., May 29, 2025 (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc. (“Zenas” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company committed to being a leader in the development and commercialization of therapies...
Cullinan Therapeutics to Host Analyst and Investor Event at 2025 ASCO Annual Meeting and Participate in Jefferies 2025 Global Healthcare Conference
GlobeNewswire, Inc.
·
May 29, 2025
CAMBRIDGE, Mass., May 29, 2025 (GLOBE NEWSWIRE) -- Cullinan Therapeutics, Inc. (Nasdaq: CGEM; “Cullinan”), a biopharmaceutical company focused on developing modality-agnostic targeted therapies, today announced its management team will host a...
Dianthus Therapeutics to Webcast Presentation at the Jefferies Global Healthcare Conference
GlobeNewswire, Inc.
·
May 29, 2025
NEW YORK and WALTHAM, Mass., May 29, 2025 (GLOBE NEWSWIRE) -- Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a clinical-stage biotechnology company dedicated to advancing the next generation of antibody complement therapeutics to treat severe...
BioStem Technologies to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference
GlobeNewswire, Inc.
·
May 29, 2025
POMPANO BEACH, Fla., May 29, 2025 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC: BSEM), a leading MedTech company focused on the development, manufacturing, and commercialization of placental-derived products for advanced wound care,...
Prescription Pharmacy Bags Market Share Analysis Poised for Robust Growth Through 2035 Amid Healthcare Demand | FMI
EIN Presswire
·
May 29, 2025
Pharmacy bags boost branding, safety, and hygiene. Growth lies in AI, robotics, tamper-evident tech, and sustainable, biodegradable packaging solutions. NEWARK, DE, UNITED STATES, May 29, 2025 /EINPresswire.com/ -- The prescription pharmacy bags...
Growing Healthcare Costs Disproportionately Affect Over 70 Million Disabled Americans
EIN Presswire
·
May 28, 2025
Enhanced training and new developments in software improve health outcomes and decrease healthcare costs. CLEARWATER, FL, UNITED STATES, May 28, 2025 /EINPresswire.com/ -- As healthcare spending remains at an all-time high, the cost of care for...
Gov. Reynolds awards $2.94 million in new healthcare grants to boost local workforce
Iowa Workforce Development
·
May 28, 2025
For Immediate Release Date: May 28, 2025 Contacts: Mason Mauro, (515) 745-2840, mason.mauro@governor.iowa.gov Jesse Dougherty, (515) 725-5487, communications@iwd.iowa.gov Today, Governor Kim Reynolds announced new grant awards for healthcare...
SI-BONE to Present at Goldman Sachs 46th Global Healthcare Conference on June 10, 2025
GlobeNewswire, Inc.
·
May 28, 2025
SANTA CLARA, Calif., May 28, 2025 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving sacropelvic disorders, today announced that the company will be participating in the upcoming 2025 Goldman Sachs 46th...
Nyxoah to Present at the Jefferies Global Healthcare Conference
GlobeNewswire, Inc.
·
May 28, 2025
Nyxoah to Present at the Jefferies Global Healthcare Conference Mont-Saint-Guibert, Belgium – May 28, 2025, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company that...
Healios K.K. to Present at the 2025 Jefferies Global Healthcare Conference
GlobeNewswire, Inc.
·
May 28, 2025
NEW YORK, May 28, 2025 (GLOBE NEWSWIRE) -- HEALIOS K.K. (“Healios”) is pleased to announce that Richard Kincaid, Chief Financial Officer, will present at the 2025 Jefferies Global Healthcare Conference in New York City as follows: Date & Time:...
Vir Biotechnology to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference 2025
Business Wire
·
May 28, 2025
Vir Biotechnology, Inc. (Nasdaq: VIR), today announced that Marianne De Backer, M.Sc., Ph.D., MBA, Chief Executive Officer, will participate in a fireside chat at the Goldman Sachs 46th Annual Global Healthcare Conference 2025 on Tuesday, June 10...